U.S. market Closed. Opens in 17 hours 24 minutes

MACK | Merrimack Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A144.27M89.26M102.76M47.79M48.92M34.22M20.30M2.15M
Cost of RevenueN/A445.00KN/AN/A2.23MN/AN/A6.91M46.00KN/AN/AN/A100.63M58.28M37.66M
Gross ProfitN/A-445.00KN/AN/A-2.23MN/AN/A137.36M89.21M102.76M-99.35M-76.94M-66.42M-37.97M-35.51M
Operating Expenses2.18M2.17M2.62M5.01M27.27M65.58M95.77M241.65M218.78M169.01M168.33M141.66M14.45M11.38M12.18M
Selling, General & Admin2.18M2.17M2.62M5.01M16.17M15.60M28.45M80.73M57.80M30.52M21.19M15.80MN/AN/AN/A
Research & DevelopmentN/AN/AN/AN/A11.10M49.97M67.31M160.92M160.99M138.50M147.14M125.86MN/AN/AN/A
Other Operating ExpensesN/AN/AN/A-191.00K370.00K-3.23MN/AN/AN/AN/AN/AN/A14.45M11.38M12.18M
Operating Income-2.18M-1.73M-2.47M-2.87M-22.36M-65.58M-95.77M-104.28M-129.57M-66.26M-120.54M-92.74M-80.87M-49.35M-47.69M
Other Expenses / Income1.01M188.00K20.00K-141.00K-381.00K-3.23M-22.64M-49.23M-18.22M-17.30M-10.14M988.00K1.19M-805.00K-4.79M
Before Tax Income-1.17M-1.54M-2.45M-3.01M-22.74M-68.46M-118.40M-153.52M-147.79M-83.56M-130.69M-91.75M-79.68M-50.16M-52.48M
Income Tax Expenses12.00K3.00K3.00K14.00K-1.47M-7.70M-42.40M-13.22MN/AN/AN/AN/AN/AN/A-3.40M
Net Income-1.18M-1.54M-2.46M-3.03M-21.27M-40.51M472.03M-151.74M-147.96M-83.29M-130.93M-91.28M-79.22M-50.10M-49.07M
Interest ExpensesN/A-188.00KN/AN/A1.53M956.00K34.65M43.65M19.23M18.23M10.94M553.00K13.00K3.73M4.91M
Basic Shares Outstanding14.30M13.52M13.41M13.38M13.35M13.34M13.23M12.53M11.14M10.44M9.89M7.28M1.13M1.13M1.13M
Diluted Shares Outstanding14.30M13.52M13.41M13.38M13.35M13.34M13.23M12.53M11.14M10.44M9.89M7.28M1.13M1.13M1.13M
EBITDA-2.18M-2.62M-2.76M-5.15M-23.89M-63.43M469.50M-115.07M-124.44M-61.84M-117.40M-87.06M-73.88M-42.00M-44.81M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%-79.76%-139.41%-60.18%-245.67%-177.96%-215.94%-206.84%-2,086.17%
EBIT-1.17M-1.73M-2.45M-3.01M-21.21M-47.24M464.28M-121.32M-128.72M-65.06M-119.99M-90.72M-79.21M-46.38M-47.57M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%-84.09%-144.22%-63.32%-251.09%-185.45%-231.51%-228.41%-2,214.43%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙